United States · FDA National Drug Code directory
Clonidine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-445_490edb25-d3c2-8b45-e063-6394a90a9bc2
- Product NDC
- 51655-445
- Form
- TABLET
- Composition / generic term
- Clonidine hydrochloride
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201001
- Source listing expiry
- 20271231
Source-listed ingredients
- CLONIDINE HYDROCHLORIDE — .1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET in 1 BOTTLE, PLASTIC (51655-445-18) · 51655-445-18
- 60 TABLET in 1 BOTTLE, PLASTIC (51655-445-25) · 51655-445-25
- 90 TABLET in 1 BOTTLE, PLASTIC (51655-445-26) · 51655-445-26
- 30 TABLET in 1 BOTTLE, PLASTIC (51655-445-52) · 51655-445-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →